Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell Receptors
Virus-specific CD8<sup>+</sup> T cells are crucial in controlling chronic human viral infections such as HIV-1, but the effect of persistent antigen exposure on T cell repertoire formation is not well understood. In this study, we examined epitope-specific CD8<sup>+</sup> T cell repertoires in people living with HIV-1, where duration of viremia following hyperacute infection was modulated by the time of initiation of continuous suppressive antiretroviral therapy (ART). After ART-induced undetectable viremia in persons expressing the same HLA class I allele, we analyzed the impact of early (n=6) versus delayed (n=6) ART initiation on the clonotypic composition, clonotypic cross-reactivity, functional avidity and memory differentiation profile of the HIV-specific T cell repertoire restricted by HLA-B*58:01. Using a panel of barcoded tetramers, we mapped T cell receptor (TCR) clonotypes specific for three dominant epitopes and their variants. Both groups exhibited polyclonal TCR repertoires with evidence of cross-reactivity, which was significantly enriched in donors with prolonged antigen exposure. Within this cohort, broadly cross-reactive clonotypes capable of recognizing all autologous variants were identified, but these were rare (<1%). Early ART initiation preserved repertoires characterized by higher-avidity TCRs and a relative enrichment of transitional memory CD8<sup>+</sup> T cell subsets. These functional differences were not associated with differences in TRBV gene sharing, indicating that ART timing shapes repertoire quality and memory differentiation without altering TRBV gene bias. These findings demonstrate how antigen suppression dynamics differentially shape the breadth, functional sensitivity, and memory composition of the HIV-specific TCR repertoire, with implications for T cell-directed immunotherapies and HIV cure strategies.
Authors
- Michael E. Birnbaum (ORCID: https://orcid.org/0000-0002-2281-3518)
- Kate B. Juergens
- Gaurav D. Gaiha (ORCID: https://orcid.org/0000-0001-6875-4472)
- Kamini Gounder (ORCID: https://orcid.org/0000-0002-1674-6021)
- K. Reddy
- David R. Collins (ORCID: https://orcid.org/0000-0001-7903-346X)
- Omolara O. Baiyegunhi (ORCID: https://orcid.org/0000-0001-8361-5534)
- Musie Ghebremichael (ORCID: https://orcid.org/0000-0002-8572-1944)
- Ahmed S. Fahad (ORCID: https://orcid.org/0000-0002-5088-9333)
- Funsho Ogunshola (ORCID: https://orcid.org/0000-0002-5655-4905)
- Brandon J. DeKosky (ORCID: https://orcid.org/0000-0001-6406-0836)
- T. Ndung'u
- Anurag Mishra (ORCID: https://orcid.org/0000-0002-5378-7551)
- Liza Vecchiarello
- B. Walker
- Sophia Cheever
- Krista Dong
- A. M. Nathan
- Marius Allombert (ORCID: https://orcid.org/0009-0007-9098-0418)
- Anabelle Webber
- Nishant K Singh
- Vincent Butty
- Zacharia Habte
- Alicja Piechocka-Trocha
- Xiaolong Li
- Nasreen Ismail
Institutions
- University of Science and Technology of China (CN)
- Howard Hughes Medical Institute (US)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- Ragon Institute of MGH, MIT and Harvard (US)
- Africa Health Research Institute (ZA)
- Center for Cancer Research (US)
- University College London (GB)
- Massachusetts Institute of Technology (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-02-02
- DOI
- https://doi.org/10.64898/2026.01.29.702605
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00